v3.26.1
Share-Based Compensation
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The components of the Company’s share-based compensation expense were as follows:
Three Months Ended June 30,
Six Months Ended June 30,
(in thousands)20262025
2026
2025
Stock options$195 $795 $752 $2,314 
Restricted stock2,744 3,003 6,166 6,330 
Performance vested restricted stock units1,305 7,155 5,618 12,724 
Total share-based compensation expense$4,244 $10,953 $12,536 $21,368 
A summary of the share-based award activity during the six months ended June 30, 2026 is presented below:
Stock OptionsRestricted StockPerformance Vested
Restricted Stock Units
OptionsWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life		SharesWeighted
Average
Grant Date
Fair Value		SharesWeighted
Average
Grant Date
Fair Value
Outstanding as of January 1, 2026695,083 $110.98 343,165 $138.02 444,811 $138.89 
Granted— — 153,792 107.78 135,539 151.07 
Performance-based leveraging (1)
— — — — (13,890)125.25 
Exercised/vested(93,133)83.95 (91,506)137.57 (115,378)128.93 
Expired(3,592)120.78 — — — — 
Forfeited(884)134.29 (13,533)121.45 (27,643)154.57 
Outstanding as of June 30, 2026597,474 $115.10 5.4 years391,918 $127.13 423,439 $144.80 
Options exercisable as of June 30, 2026534,965 $115.00 5.2 years
(1) Any revisions to the outstanding PVRSUs during the six months ended June 30, 2026 is based on the Company's performance relative to the targeted performance conditions in the respective PVRSUs.
The fair value of the restricted stock and the PVRSUs with performance conditions that were granted during the six months ended June 30, 2026 was equal to the market price of the Company’s common stock on the date of the grant. The fair value of the PVRSUs with market conditions that are based on the Company’s total shareholder return relative to a predetermined peer group was estimated using a Monte Carlo simulation method as of the date of the grant. The requisite service periods for the restricted stock and the PVRSUs was between 9 months and 48 months.